Palisade Bio's PALI-2108 will be presented at Digestive Disease Week 2025, highlighting its potential in ulcerative colitis treatment. Palisade Bio's lead program PALI-2108 has been recognized, being ...
Evoke Pharma, Inc. announced that an abstract comparing the incidence of tardive dyskinesia (TD) in patients undergoing continuous versus intermittent oral metoclopramide treatment has been accepted ...
Supplements are often marketed as quick fixes for energy, weight loss, or overall health—but not all of them are as harmless as they seem. According to doctors, some popular supplements can actually ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback